The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Ulf Gerdtham. Photo.

Ulf Gerdtham

Professor

Ulf Gerdtham. Photo.

Economic Evaluation of Interventions in Parkinson's Disease : A Systematic Literature Review

Author

  • Nafsika Afentou
  • Johan Jarl
  • Ulf-Göran Gerdtham
  • Sanjib Saha

Summary, in English

Background

Parkinson's disease (PD) management comprises of drug treatments, surgery, and physical activity/occupational therapies to relieve PD's symptoms. The aim of this study is twofold; first, to appraise recent economic evaluation studies on PD management in order to update the existing knowledge; and second, to facilitate decision making on PD management by assessing the cost‐effectiveness of all types of PD interventions.
Methods

A systematic search for studies published between 2010 and 2018 was conducted. The inclusion and exclusion of the articles were based on criteria relevant to population, intervention, comparison, outcomes, and study design (PICO). The reporting quality of the articles was assessed according to Consolidated Health Economic Evaluation Reporting Standards.
Results

Twenty‐eight articles were included, 10 of which were evaluations of drug treatments, 10 deep brain stimulation (DBS), and eight physical/occupational therapies. Among early‐stage treatments, Ti Ji dominated all physical activity interventions; however, its cost‐effectiveness should be further explored in relation to its duration, intensity, and frequency. Multidisciplinary interventions of joint medical and nonmedical therapies provided slightly better health outcomes for the same costs. In advanced PD patients, adjunct drug treatments could become more cost‐effective if introduced during early PD and, although DBS was more cost‐effective than adjunct drug therapies, the results were time‐bound.
Conclusions

Conditionally, certain PD interventions are cost‐effective. However, PD progression differs in each patient; thus, the cost‐effectiveness of individually tailored combinations of interventions that could provide more time in less severe disease states and improve patients’ and caregivers’ quality of life, should be further explored.

Department/s

  • Health Economics
  • Centre for Economic Demography
  • Department of Economics
  • EpiHealth: Epidemiology for Health

Publishing year

2019

Language

English

Pages

282-290

Publication/Series

Movement Disorders Clinical Practice

Volume

6

Issue

4

Document type

Journal article review

Publisher

John Wiley & Sons Inc.

Topic

  • Health Care Service and Management, Health Policy and Services and Health Economy

Status

Published

Research group

  • Health Economics

ISBN/ISSN/Other

  • ISSN: 2330-1619